Navigation Links
More evidence needed for scale up of mobile device technology in health
Date:2/12/2013

Despite the hundreds of pilot studies using mobile healthalso known as 'mHealth'', which describe medical and public health practice supported by mobile devices there is insufficient evidence to inform the widespread implementation and scale-up of this technology, according to international researchers writing in this week's PLOS Medicine.

There are over 6 billion mobile phone subscribers and 75% of the world has access to a mobile phone leading health care providers, researchers, and national governments to be optimistic about the opportunities mobile health has to offer. However, the authors led by Mark Tomlinson from Stellenbosch University in South Africa, question the evidence supporting the scale up of mHealth.

The authors say: "In some ways, mobile technology has a magical appeal for those interested in global public health over and above the advantages that have been proven with good evidence."

They continue: "Part of this magical promise is that mobile technologies may solve one of the most difficult problems facing global health effortsthat of structural barriers to access."

However, according to the authors while enthusiasm for effective mHealth interventions in sub-Saharan Africa is high, little is known about their efficacy or effectiveness.

They say: "The current wave of mHealth interventions are the equivalent of black boxes. Each small entrepreneur or researcher includes whatever bells and whistles that their funding allows in an attempt to demonstrate efficacy."

The authors argue that potential innovative research designs such as multi-factorial strategies, randomized controlled trials, and data farming may provide this evidence base and make several recommendations for the way forward.

The authors also argue that major donors could invest in creating a robust set of standards and a platform that can inform and support local adaptation of mHealth applications. The standardized features of the platform could then be available to all local technicians committed to improving the health of their local communities.

The authors conclude: "We also believe a global strategy for programmatic examination of the optimal features of the mobile platforms is needed."


'/>"/>

Contact: Sumrina Yousufzai
syousufzai@plos.org
415-568-3164
Public Library of Science
Source:Eurekalert

Related biology technology :

1. More evidence for longevity pathway
2. New Epidemiological Data Provide Additional Safety Evidence for Lantus®
3. endpoint Adopts New Technology To Boast Most Robust IVR Validation Objective Evidence and Decrease IVR Build Timelines
4. First Evidence that Adipose Stem Cell-Based Critical Limb Ischemia Treatment is Safe & Effective is published in Circulation Journal by Lead Investigator Dr. Han Cheol Lee of Pusan National University
5. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
6. Fundamental steps needed now in global redesign of Earth system governance
7. Larger refuges needed to sustain success of transgenic corn
8. New life sciences R&D model based on real-time learning and data-sharing needed to sustain innovation
9. UMass Amherst, Harvard experts say better systems needed for medical device cybersecurity
10. A firm molecular handshake needed for hearing and balance
11. Sandy Mold Extends Its Health Risks to Hired Cleaners; My Cleaning Products Says Complete Mold Treatment Gear and Molderizer are Needed to Stop Mold and Its Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CA (PRWEB) , ... June 27, 2016 , ... ... for clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT ... care circle with the physician and clinical trial team. , Using the CONSULT module, ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
Breaking Biology News(10 mins):